Showing results (171-180 of 429) with videos related to
Sort By:
Pageof 43
ISRN Oncology|May 22, 2013
Does Time between Imaging Diagnosis and Initiation of Radiotherapy Impact Survival after Whole-Brain Radiotherapy for Brain Metastases?Carsten Nieder, Oddvar Spanne, Ellinor Haukland, et al.Radiation Oncology (London, England)|July 14, 2014
Stereotactic radiosurgery (SRS) for brain metastases: a systematic reviewCarsten Nieder, Anca L Grosu, Laurie E GasparOncology Letters|August 15, 2014
Normal tissue studies in radiation oncology: A systematic review of highly cited articles and citation patternsCarsten Nieder, Nicolaus H Andratschke, Anca L GrosuInternational Journal of Circumpolar Health|May 24, 2019
Management of patients with metastatic prostate cancer (mPC) in a rural part of North Norway with a scattered population: does living near the department of oncology translate into a different pattern of care and survival?Carsten Nieder, Astrid Dalhaug, Ellinor Haukland, et al.Oncology Letters|October 5, 2016
Impact of intense systemic therapy and improved survival on the use of palliative radiotherapy in patients with bone metastases from prostate cancerCarsten Nieder, Ellinor Haukland, Bård Mannsåker, et al.Oncology Research and Treatment|February 15, 2023
Patterns of Care and Survival in Cancer Patients with Brain Metastases Receiving Immune Checkpoint InhibitorsCarsten Nieder, Bård Mannsåker, Luka Stanisavljevic, et al.Clinical Neurology and Neurosurgery|April 21, 2012
Glioblastoma research 2006-2010: pattern of citation and systematic review of highly cited articlesCarsten Nieder, Sabrina T Astner, Anca L GrosuCases Journal|October 2, 2008
Presentation and course of brain metastases from breast cancer in a paranoid-schizophrenic patient: A case reportAstrid Dalhaug, Adam Pawinski, Jan Norum, et al.Scandinavian Journal of Urology|February 17, 2022
Feasibility and efficacy of early docetaxel plus androgen deprivation therapy for metastatic hormone-sensitive prostate cancer in a rural health care settingCarsten Nieder, Luka Stanisavljevic, Astrid Dalhaug, et al.Anticancer Research|May 31, 2022
Survival and Early Death Within Three Months from the Start of Immune Checkpoint Inhibitors in Patients With Different Types of CancerCarsten Nieder, Siv Gyda Aanes, Ellinor C HauklandPageof 43